BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
BEGIN:VEVENT
DTSTAMP:20240328T125047Z
UID:90f9da25-8c67-4cdc-9c49-a1d9121c4784
DTSTART:20211027T140000
DTEND:20211028T140000
CLASS:PRIVATE
DESCRIPTION:
\n
\n
\nWith the explosive excitement and clinical proof of concept utilizing CD
47 approaches\, 2020 is the year for macrophage development\, as we witnes
s greater interest and investment in new work on novel macrophage targets
outside of CD47.
\n
\nThe Macrophage-directed Therapies Summit i
s focused on optimizing the potential of macrophage therapies\, through di
rect utilization of cells or small molecule approaches to target and stimu
late macrophage cells in vivo for oncological indications and beyond.
\n
\nJoin us virtually this October as the trailblazers of macrophag
e therapeutic development\, from the likes of Carisma Therapeutics\, Faron
Pharmaceuticals\, and Verseau Therapeutics come together to advance the f
undamental understanding of macrophage biology\, avoiding on-target toxici
ties and the emerging field of macrophage cellular immunotherapy.
\n<
br />\nEarly booking and Academic discounts available - see website for mo
re details.
\n
\nhttps://macrophage-directed-therapies.com/
\n
\nContact:
\n
\ninfo@hansonwade.com
\n
\n+1 6
17 455 4188
\n
\nURLs:
\nTickets: \;https://go.evvnt.com/653684
-2?pid=1052
\nBrochure: \;https://go.evvnt.com/653684-3?pid=1052
\n
\nPrices:
\nConference Only (Drug Developer Pricing) - D
IGITAL : USD 2099.0\,
\nConference Only (Standard Pricing) - DIGITAL
: USD 2449.0\,
\nConference Only (Academic Pricing) - DIGITAL : USD 1
259.0
\n \;
SUMMARY:Macrophage-directed Therapies Summit 2020
BEGIN:VALARM
ACTION:DISPLAY
TRIGGER:-PT1H
SUMMARY:Macrophage-directed Therapies Summit 2020
END:VALARM
END:VEVENT
END:VCALENDAR